IsoRay Inc


Maxim Reiterates Buy On IsoRay Following Barrow Study Results; Keeps $5 PT

In a research report sent to investors today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on IsoRay Inc (NYSE:ISR) with a …

Maxim Maintains Buy On IsoRay Following Fiscal 1Q:15 Results

In a research report issued today, Maxim Group analyst Jason Kolbert maintained a Buy rating on IsoRay Inc (NYSE:ISR) with a $5 price target, …

Maxim Reiterates Buy On IsoRay As Its Brain Tumor Seed Shows Positive Results

In a research report published October 7, Maxim Group analyst Jason Kolbert reiterated a Buy rating on IsoRay Inc (NYSE:ISR) with a $5 price target, …

Maxim Group Maintains Buy On IsoRay Following Fiscal Year 2014 Results

In a report published today, Maxim Group analyst Jason Kolbert maintained a Buy rating on IsoRay Inc (NYSE:ISR) with a $5 price target, following …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts